Physician profile
John Eldridge
NPI 1609817394
$2,721.91
in general payments reported to CMS, 2019-2025
41 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $48.92 · 2021: $239 · 2022: $428 · 2023: $657 · 2024: $572 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546 · Education: $68.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.44 |
| Education | $68.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $378.14 | 2019-2024 | Phasix Mesh |
| Kerecis Limited | $356.71 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $152.33 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Takeda Pharmaceuticals U.S.A., INC. | $119.30 | 2021-2023 | Gattex |
| W. L. Gore & Associates, INC. | $109.26 | 2021-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Aroa Biosurgery Incorporated | $105.05 | 2022-2025 | |
| Ethicon US, LLC | $102.89 | 2019-2024 | Surgicel Nu-Knit |
| Tela Bio, INC. | $102.42 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Access Pro Medical, LLC | $94.99 | 2022 | |
| Abbvie INC. | $88.39 | 2022-2024 | |
| Innovation Technologies INC | $82.15 | 2024 | Irrisept |
| Intuitive Surgical, INC. | $81.77 | 2019 | |
| Merck Sharp & Dohme LLC | $77.71 | 2019-2022 | |
| Reapplix INC. | $77.51 | 2024 | 3c Patch Kit - Box |
| Endologix LLC | $63.11 | 2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.